Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human vaginal metagenome

ABSTRACT: The vaginal microbiota and the oral contraceptive pill

PROVIDER: PRJNA592384 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11045400.fastq.gz	Fastqsanger.gz
	SRR11045400_1.fastq.gz	Fastqsanger.gz
	SRR11045400_2.fastq.gz	Fastqsanger.gz
	SRR11045500.fastq.gz	Fastqsanger.gz
	SRR11045500_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1309

Similar Datasets

Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in humans and increases susceptibility to HIV-1 in humanized mice

Project description:The hormonal contraceptive medroxyprogesterone acetate (MPA) is associated with increased risk of human immunodeficiency virus (HIV), via incompletely understood mechanisms. Increased diversity in the vaginal microbiota modulates genital inflammation and is associated with increased HIV-1 acquisition. However, the effect of MPA on diversity of the vaginal microbiota is relatively unknown. In a cohort of female Kenyan sex workers, negative for sexually transmitted infections (STIs), with Nugent scores <7 (N=58 of 370 screened), MPA correlated with significantly increased diversity of the vaginal microbiota as assessed by 16S rRNA gene sequencing. MPA was also significantly associated with decreased levels of estrogen in the plasma, and low vaginal glycogen and α-amylase, factors implicated in vaginal colonization by lactobacilli, bacteria that are believed to protect against STIs. In a humanized mouse model, MPA treatment was associated with low serum estrogen, low glycogen and enhanced HIV-1 susceptibility. The mechanism by which the MPA mediated changes in the vaginal microbiota may contribute to HIV-1 susceptibility in humans appears to be independent of inflammatory cytokines and/or activated T cells. Altogether, these results suggest MPA-induced hypo-estrogenism may alter key metabolic components that are necessary for vaginal colonization by certain bacterial species including lactobacilli, and allow for greater bacterial diversity in the vaginal microbiota.

2019-10-17 | GSE138971 | GEO

human vaginal metagenome

Project description:Characterization of vaginal microbiota

| PRJDB10578 | ENA

human vaginal metagenome

Project description:Human vaginal microbiota Metagenome

| PRJNA361427 | ENA

human vaginal metagenome

Project description:Vaginal microbiota and genitourinary menopausal symptoms

| PRJNA376456 | ENA

Differences in vaginal microbiota, host transcriptome and proteins in women with bacterial vaginosis are associated with metronidazole treatment response

Project description:Bacterial vaginosis (BV) treatment failures or recurrences are common. To identify features associated with treatment response, we compared vaginal microbiota and host ectocervical transcriptome before and after oral metronidazole therapy. Response to metronidazole is characterized by significant changes in chemokines and related transcripts suggesting that strategies to promote these pathways may prove beneficial.

2021-05-21 | GSE174799 | GEO

human vaginal metagenome

Project description:Vaginal microbiota: age dynamic and ethnic particularities of Algerian women

| PRJNA630844 | ENA

human vaginal metagenome

Project description:Vaginal microbiota of women with vs. without inflammatory bowel disease

| PRJNA849603 | ENA

human vaginal metagenome

Project description:Vaginal microbiota and mucosal immune markers in women with vulvovaginal discomfort

| PRJNA601220 | ENA

human vaginal metagenome

Project description:Vaginal microbiome